Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 90

    1.

    PALB2 variants in hereditary and unselected Finnish prostate cancer cases.

    Pakkanen S, Wahlfors T, Siltanen S, Patrikainen M, Matikainen MP, Tammela TL, Schleutker J.

    J Negat Results Biomed. 2009 Dec 15;8:12.

    PMID:
    20003494
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    A recurrent mutation in PALB2 in Finnish cancer families.

    Erkko H, Xia B, Nikkilä J, Schleutker J, Syrjäkoski K, Mannermaa A, Kallioniemi A, Pylkäs K, Karppinen SM, Rapakko K, Miron A, Sheng Q, Li G, Mattila H, Bell DW, Haber DA, Grip M, Reiman M, Jukkola-Vuorinen A, Mustonen A, Kere J, Aaltonen LA, Kosma VM, Kataja V, Soini Y, Drapkin RI, Livingston DM, Winqvist R.

    Nature. 2007 Mar 15;446(7133):316-9. Epub 2007 Feb 7.

    PMID:
    17287723
    [PubMed - indexed for MEDLINE]
    3.

    Penetrance analysis of the PALB2 c.1592delT founder mutation.

    Erkko H, Dowty JG, Nikkilä J, Syrjäkoski K, Mannermaa A, Pylkäs K, Southey MC, Holli K, Kallioniemi A, Jukkola-Vuorinen A, Kataja V, Kosma VM, Xia B, Livingston DM, Winqvist R, Hopper JL.

    Clin Cancer Res. 2008 Jul 15;14(14):4667-71.

    PMID:
    18628482
    [PubMed - indexed for MEDLINE]
    Free Article
    4.

    The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype.

    Heikkinen T, Kärkkäinen H, Aaltonen K, Milne RL, Heikkilä P, Aittomäki K, Blomqvist C, Nevanlinna H.

    Clin Cancer Res. 2009 May 1;15(9):3214-22. Epub 2009 Apr 21.

    PMID:
    19383810
    [PubMed - indexed for MEDLINE]
    Free Article
    5.

    Identification of germline MLH1 alterations in familial prostate cancer.

    Fredriksson H, Ikonen T, Autio V, Matikainen MP, Helin HJ, Tammela TL, Koivisto PA, Schleutker J.

    Eur J Cancer. 2006 Nov;42(16):2802-6. Epub 2006 Sep 11.

    PMID:
    16963262
    [PubMed - indexed for MEDLINE]
    6.

    Evidence against PALB2 involvement in Icelandic breast cancer susceptibility.

    Gunnarsson H, Arason A, Gillanders EM, Agnarsson BA, Johannesdottir G, Johannsson OT, Barkardottir RB.

    J Negat Results Biomed. 2008 Jul 17;7:5.

    PMID:
    18637200
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    7.

    PALB2 sequence variants in young South African breast cancer patients.

    Sluiter M, Mew S, van Rensburg EJ.

    Fam Cancer. 2009;8(4):347-53. Epub 2009 Mar 31.

    PMID:
    19333784
    [PubMed - indexed for MEDLINE]
    8.

    Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women.

    Foulkes WD, Ghadirian P, Akbari MR, Hamel N, Giroux S, Sabbaghian N, Darnel A, Royer R, Poll A, Fafard E, Robidoux A, Martin G, Bismar TA, Tischkowitz M, Rousseau F, Narod SA.

    Breast Cancer Res. 2007;9(6):R83.

    PMID:
    18053174
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    9.

    Analysis of FANCB and FANCN/PALB2 fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families.

    García MJ, Fernández V, Osorio A, Barroso A, Llort G, Lázaro C, Blanco I, Caldés T, de la Hoya M, Ramón Y Cajal T, Alonso C, Tejada MI, San Román C, Robles-Díaz L, Urioste M, Benítez J.

    Breast Cancer Res Treat. 2009 Feb;113(3):545-51. Epub 2008 Feb 27.

    PMID:
    18302019
    [PubMed - indexed for MEDLINE]
    10.

    Analysis of large deletions in BRCA1, BRCA2 and PALB2 genes in Finnish breast and ovarian cancer families.

    Pylkäs K, Erkko H, Nikkilä J, Sólyom S, Winqvist R.

    BMC Cancer. 2008 May 26;8:146.

    PMID:
    18501021
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    11.

    Analysis of the gene coding for the BRCA2-interacting protein PALB2 in hereditary prostate cancer.

    Tischkowitz M, Sabbaghian N, Ray AM, Lange EM, Foulkes WD, Cooney KA.

    Prostate. 2008 May 1;68(6):675-8.

    PMID:
    18288683
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    12.

    The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.

    Cao AY, Huang J, Hu Z, Li WF, Ma ZL, Tang LL, Zhang B, Su FX, Zhou J, Di GH, Shen KW, Wu J, Lu JS, Luo JM, Yuan WT, Shen ZZ, Huang W, Shao ZM.

    Breast Cancer Res Treat. 2009 Apr;114(3):457-62. Epub 2008 Apr 30.

    PMID:
    18446436
    [PubMed - indexed for MEDLINE]
    13.

    A novel germline PALB2 deletion in Polish breast and ovarian cancer patients.

    Dansonka-Mieszkowska A, Kluska A, Moes J, Dabrowska M, Nowakowska D, Niwinska A, Derlatka P, Cendrowski K, Kupryjanczyk J.

    BMC Med Genet. 2010 Feb 2;11:20.

    PMID:
    20122277
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    Germ-line alterations in MSR1 gene and prostate cancer risk.

    Seppälä EH, Ikonen T, Autio V, Rökman A, Mononen N, Matikainen MP, Tammela TL, Schleutker J.

    Clin Cancer Res. 2003 Nov 1;9(14):5252-6.

    PMID:
    14614006
    [PubMed - indexed for MEDLINE]
    Free Article
    15.

    ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer.

    Rökman A, Ikonen T, Mononen N, Autio V, Matikainen MP, Koivisto PA, Tammela TL, Kallioniemi OP, Schleutker J.

    Cancer Res. 2001 Aug 15;61(16):6038-41.

    PMID:
    11507049
    [PubMed - indexed for MEDLINE]
    Free Article
    16.

    Evaluation of variants in the CHEK2, BRIP1 and PALB2 genes in an Irish breast cancer cohort.

    McInerney NM, Miller N, Rowan A, Colleran G, Barclay E, Curran C, Kerin MJ, Tomlinson IP, Sawyer E.

    Breast Cancer Res Treat. 2010 May;121(1):203-10. Epub 2009 Sep 18. Erratum in: Breast Cancer Res Treat. 2012 Jan;131(2):729.

    PMID:
    19763819
    [PubMed - indexed for MEDLINE]
    17.

    Analysis of PALB2/FANCN-associated breast cancer families.

    Tischkowitz M, Xia B, Sabbaghian N, Reis-Filho JS, Hamel N, Li G, van Beers EH, Li L, Khalil T, Quenneville LA, Omeroglu A, Poll A, Lepage P, Wong N, Nederlof PM, Ashworth A, Tonin PN, Narod SA, Livingston DM, Foulkes WD.

    Proc Natl Acad Sci U S A. 2007 Apr 17;104(16):6788-93. Epub 2007 Apr 9.

    PMID:
    17420451
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    18.

    A PALB2 germline mutation associated with hereditary breast cancer in Italy.

    Papi L, Putignano AL, Congregati C, Piaceri I, Zanna I, Sera F, Morrone D, Genuardi M, Palli D.

    Fam Cancer. 2010 Jun;9(2):181-5. Epub 2009 Sep 18.

    PMID:
    19763884
    [PubMed - indexed for MEDLINE]
    19.

    PALB2 mutations in familial breast and pancreatic cancer.

    Hofstatter EW, Domchek SM, Miron A, Garber J, Wang M, Componeschi K, Boghossian L, Miron PL, Nathanson KL, Tung N.

    Fam Cancer. 2011 Jun;10(2):225-31.

    PMID:
    21365267
    [PubMed - indexed for MEDLINE]
    20.

    A major locus for hereditary prostate cancer in Finland: localization by linkage disequilibrium of a haplotype in the HPCX region.

    Baffoe-Bonnie AB, Smith JR, Stephan DA, Schleutker J, Carpten JD, Kainu T, Gillanders EM, Matikainen M, Teslovich TM, Tammela T, Sood R, Balshem AM, Scarborough SD, Xu J, Isaacs WB, Trent JM, Kallioniemi OP, Bailey-Wilson JE.

    Hum Genet. 2005 Aug;117(4):307-16. Epub 2005 May 20. Erratum in: Hum Genet. 2005 Nov;118(2):307.

    PMID:
    15906096
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk